Investors

Insider Transactions

Date Name Title Type Shares Traded Sorted Ascending Price Range
Apr 1, 2014 vagelos p roy Officer Disposition (Non Open Market) 700 n/a
Aug 7, 2014 stahl neil Officer Sell 741 340.39 - 341.03
Jul 1, 2014 vagelos p roy Officer Disposition (Non Open Market) 756 n/a
Jan 10, 2014 vagelos p roy Officer Disposition (Non Open Market) 764 n/a
Nov 5, 2007 goldstein joseph l Director Automatic Sell 800 20.64 - 20.87
Nov 5, 2007 goldstein joseph l Director Option Execute 800 7.66
Jul 5, 2013 vagelos p roy Officer Disposition (Non Open Market) 921 n/a
Dec 16, 2014 mccorkle douglas s Officer Sell 943 410.00
Feb 20, 2015 brown michael s Director Sell 1,000 422.72
Nov 5, 2015 brown michael s Director Disposition (Non Open Market) 1,000 n/a
Feb 27, 2014 brown michael s Director Sell 1,000 335.00
Feb 20, 2015 brown michael s Director Option Execute 1,000 57.11
Feb 26, 2014 brown michael s Director Option Execute 1,000 57.11
Dec 19, 2008 gilman alfred g Director Disposition (Non Open Market) 1,000 n/a
Oct 21, 2010 gilman alfred g Director Disposition (Non Open Market) 1,000 n/a
Feb 25, 2014 goldstein joseph l Director Sell 1,000 338.86
Feb 20, 2014 goldstein joseph l Director Sell 1,000 326.96 - 327.17
Aug 23, 2013 goldstein joseph l Director Sell 1,000 238.29
Nov 6, 2013 goldstein joseph l Director Sell 1,000 300.74
Feb 12, 2014 goldstein joseph l Director Sell 1,000 320.62
Showing 41-60 of 1021 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)